{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:34:04Z","timestamp":1791272044549,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.neuropharm.2007.10.017","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T05:14:59Z","timestamp":1196486099000},"page":"454-463","source":"Crossref","is-referenced-by-count":59,"title":["The aspirin metabolite salicylate enhances neuronal excitation in rat hippocampal CA1 area through reducing GABAergic inhibition"],"prefix":"10.1016","volume":"54","author":[{"given":"Neng","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Chun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Le","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.10.017_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neures.2004.07.003","article-title":"Effects of salicylate on spontaneous activity in inferior colliculus brain slices","volume":"50","author":"Basta","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.wco.0000162855.75391.6a","article-title":"The multiple facets of gamma-aminobutyric acid dysfunction in epilepsy","volume":"18","author":"Ben-Ari","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0301-0082(00)00027-7","article-title":"Auditory sensori-neural alterations induced by salicylate","volume":"62","author":"Cazals","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nature01868","article-title":"Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain","volume":"424","author":"Coull","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib5","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1126\/science.270.5244.2017","article-title":"The effect of sodium salicylate and aspirin on NF-kappa B","volume":"270","author":"Frantz","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib6","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/01.STR.0000174189.81153.85","article-title":"Risk of hemorrhagic stroke with aspirin use: an update","volume":"36","author":"Gorelick","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib8","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1046\/j.1460-9568.1999.00709.x","article-title":"Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid","volume":"11","author":"Halliwell","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archotol.1986.03780100038004","article-title":"Differential uptake of salicylate in serum, cerebrospinal fluid, and perilymph","volume":"112","author":"Jastreboff","year":"1986","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.280.5367.1268","article-title":"Aspirin-like molecules that covalently inactivate cyclooxygenase-2","volume":"280","author":"Kalgutkar","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1152\/jn.1961.24.3.225","article-title":"Electrophysiology of hippocampal neurons. I. Sequential invasion and synaptic organization","volume":"24","author":"Kandel","year":"1961","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/070674370404900705","article-title":"GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia","volume":"49","author":"Lanctot","year":"2004","journal-title":"Can. J. Psychiatry."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2004.07.037","article-title":"Effects of salicylate on transient outward and delayed rectifier potassium channels in rat inferior colliculus neurons","volume":"369","author":"Liu","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.heares.2004.03.006","article-title":"Effects of salicylate on voltage-gated sodium channels in rat inferior colliculus neurons","volume":"193","author":"Liu","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature04050","article-title":"Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons","volume":"437","author":"Liu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.heares.2005.03.028","article-title":"Salicylate blocks L-type calcium channels in rat inferior colliculus neurons","volume":"205","author":"Liu","year":"2005","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0896-6273(00)81150-2","article-title":"Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP","volume":"26","author":"Lu","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib20","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1523\/JNEUROSCI.4439-05.2006","article-title":"Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats","volume":"26","author":"Mallet","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0006-8993(90)91323-9","article-title":"Serotonin suppresses N-methyl-d-Aspartate responses in acutely isolated spinal dorsal horn neurons of the rat","volume":"525","author":"Murase","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0306-4522(00)00158-5","article-title":"The aspirin metabolite sodium salicylate causes focal cerebral hemorrhage and cell death in rats with kainic acid-induced seizures","volume":"99","author":"Najbauer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-3806(98)00061-3","article-title":"Development of a transient increase in recurrent inhibition and paired-pulse facilitation in hippocampal CA1 region. Brain Res","volume":"108","author":"Papatheodoropoulos","year":"1998","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0306-4522(99)00492-3","article-title":"Chronic sodium salicylate treatment exacerbates brain neurodegeneration in rats infected with Trypanosoma brucei","volume":"96","author":"Quan","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/syn.890210302","article-title":"From ion currents to genomic analysis: recent advances in GABAA receptor research","volume":"21","author":"Rabow","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib27","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1460-9568.1993.tb00957.x","article-title":"Functional heterogeneity of hippocampal GABAA receptors","volume":"5","author":"Schonrock","year":"1993","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1471-4159.2001.00274.x","article-title":"gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia","volume":"77","author":"Schwartz-Bloom","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0028-3908(02)00123-5","article-title":"Relative picrotoxin insensitivity distinguishes ionotropic GABA receptor-mediated IPSCs in hippocampal interneurons","volume":"43","author":"Semyanov","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.64.3.753","article-title":"Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug","volume":"64","author":"Sinkkonen","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2004.11.023","article-title":"Aspirin resistance in stroke: 2004","volume":"229\/230","author":"Sztriha","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1542\/peds.62.5S.873","article-title":"Pathophysiology of aspirin overdosage toxicity, with implications for management","volume":"62","author":"Temple","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0773.2002.910201.x","article-title":"The public health potential of aspirin","volume":"91","author":"Vainio","year":"2002","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib34","first-page":"3","article-title":"Mechanism of action of antiinflammatory drugs","volume":"20","author":"Vane","year":"1998","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.heares.2006.03.004","article-title":"Sodium salicylate reduces inhibitory postsynaptic currents in neurons of rat auditory cortex","volume":"215","author":"Wang","year":"2006","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuropharm.2007.10.017_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00001756-200505310-00007","article-title":"Sodium salicylate reduces gamma aminobutyric acid-induced current in rat spinal dorsal horn neurons","volume":"16","author":"Xu","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.10.017_bib37","doi-asserted-by":"crossref","unstructured":"Zhang, L.H., Gong, N., Fei, D., Xu, L., Xu, T.L. Glycine uptake regulates hippocampal network activity via glycine receptor-mediated tonic inhibition. Neuropsychopharmacology, in press, doi:10.1038\/sj.npp.1301449.","DOI":"10.1038\/sj.npp.1301449"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807003449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807003449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T01:55:11Z","timestamp":1684115711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807003449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0028390807003449"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.10.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}